1. Home
  2. VERU vs DSY Comparison

VERU vs DSY Comparison

Compare VERU & DSY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VERU
  • DSY
  • Stock Information
  • Founded
  • VERU 1971
  • DSY 2020
  • Country
  • VERU United States
  • DSY China
  • Employees
  • VERU N/A
  • DSY N/A
  • Industry
  • VERU Biotechnology: Pharmaceutical Preparations
  • DSY
  • Sector
  • VERU Health Care
  • DSY
  • Exchange
  • VERU Nasdaq
  • DSY Nasdaq
  • Market Cap
  • VERU 85.5M
  • DSY 72.0M
  • IPO Year
  • VERU 1990
  • DSY N/A
  • Fundamental
  • Price
  • VERU $3.60
  • DSY $1.09
  • Analyst Decision
  • VERU Strong Buy
  • DSY
  • Analyst Count
  • VERU 3
  • DSY 0
  • Target Price
  • VERU $33.33
  • DSY N/A
  • AVG Volume (30 Days)
  • VERU 227.6K
  • DSY 35.7K
  • Earning Date
  • VERU 08-12-2025
  • DSY 01-01-0001
  • Dividend Yield
  • VERU N/A
  • DSY N/A
  • EPS Growth
  • VERU N/A
  • DSY 120.37
  • EPS
  • VERU N/A
  • DSY 0.01
  • Revenue
  • VERU $16,886,419.00
  • DSY $7,323,356.00
  • Revenue This Year
  • VERU N/A
  • DSY N/A
  • Revenue Next Year
  • VERU N/A
  • DSY N/A
  • P/E Ratio
  • VERU N/A
  • DSY $87.66
  • Revenue Growth
  • VERU 337.24
  • DSY 16.37
  • 52 Week Low
  • VERU $2.64
  • DSY $0.95
  • 52 Week High
  • VERU $14.20
  • DSY $6.98
  • Technical
  • Relative Strength Index (RSI)
  • VERU 35.24
  • DSY 37.74
  • Support Level
  • VERU $2.64
  • DSY $1.07
  • Resistance Level
  • VERU $3.69
  • DSY $1.08
  • Average True Range (ATR)
  • VERU 0.39
  • DSY 0.08
  • MACD
  • VERU 0.02
  • DSY -0.00
  • Stochastic Oscillator
  • VERU 40.27
  • DSY 17.86

About VERU Veru Inc.

Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.

About DSY Big Tree Cloud Holdings Limited Ordinary Shares

Big Tree Cloud Holdings Ltd is a consumer-oriented, mission-driven, and technology-empowered company engaged in the development, production, and sales of personal care products and other consumer goods. In particular, it is focused on the development and production of feminine pads and other feminine hygiene products. Through its platform, the company focuses on high-quality product development, deep customer engagement, and efficient sales and marketing.

Share on Social Networks: